India to resume supply of vaccines from Covid-19 to COVAX

Source : 112 Ukraine

Deliveries of Indian vaccine to the global initiative COVAX stopped in April due to exacerbation of the disease in the country
17:45, 9 November 2021

Open source

India will resume supplies of Covid-19 vaccines to the global COVAX Covid-19 immunization initiative in a few weeks, sources in the field of healthcare in India stated, Reuters reports.

"India could resume deliveries of COVID-19 shots to global vaccine-sharing platform COVAX in a few weeks for the first time since April," the message reads.

The Indian Ministry of Health reported that Indian states had more than 159 million unused doses of various vaccines as vaccination in the country slowed after 79% of the 944 million adults received a single dose and 37% received two doses.

Thus, COVAX officials have already begun planning the release of the Indian vaccine Covishield (licensed version of AstraZeneca) for different countries.

Deliveries of Indian vaccine to the global COVAX initiative were suspended in April due to the emergence of a new strain of COVID-19 and an increase in the number of cases in the country. It was then that the Serum Institute in India, the world's largest vaccine manufacturer, produced up to 240 million doses of Covishield (a licensed version of AstraZeneca) per month since April, when all exports were stopped, for vaccination of their own people.

Over the past 24hrs, more than 10,000 cases of Covid-19 and more than 300 deaths have been reported in India.

Over the past 24hrs, there were 490 thousand cases of Covid-19 infection in the world, about 7 thousand fatal.

Related: Over two million doses of Pfizer vaccine to be brought to Ukraine, - Health Minister

Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more